2002•American Journal of Physiology-Endocrinology and MetabolismRequires access
Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes
Hideyuki Sakoda, Takehide Ogihara, Motonobu Anai, Midori Fujishiro, Hiraku Ono, Yukiko Onishi, Hideki Katagiri, Miho Abe, Yasushi Fukushima, Nobuhiro Shojima, Kouichi Inukai, Masatoshi Kikuchi, Yoshitomo Oka, Tomoichiro Asano
Open publisher page 96 citations
Abstract
5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) reportedly activates AMP-activated protein kinase (AMPK) and stimulates glucose uptake by skeletal muscle cells. In this study, we investigated the role of AMPK in AICAR-induced glucose uptake by 3T3-L1 adipocytes and rat soleus muscle cells by overexpressing wild-type and dominant negative forms of the AMPKalpha2 subunit by use of adenovirus-mediated gene transfer. Overexpression of the dominant negative mutant had no effect on AICAR-induced glucose transport in adipocytes, although AMPK activation was almost completely abolished. This suggests that AICAR-induced glucose uptake by 3T3-L1 adipocytes is independent of AMPK activation. By contrast, overexpression of the dominant negative AMPKalpha2 mutant in muscle markedly suppressed both AICAR-induced glucose uptake and AMPK activation, although insulin-induced uptake was unaffected. Overexpression of the wild-type AMPKalpha2 subunit significantly increased AMPK activity in muscle but did not enhance glucose uptake. Thus, although AMPK activation may not, by itself, be sufficient to increase glucose transport, it appears essential for AICAR-induced glucose uptake in muscle.